Ani Pharmaceuticals (ANIP) Assets (2010 - 2026)
Ani Pharmaceuticals' Assets came in at $1.49 billion for Q2 2026, up 11.3% from $1.34 billion a year earlier and up 5.1% from the prior quarter.
Analysis
Ani Pharmaceuticals (ANIP) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Ani Pharmaceuticals' Assets was $1.44 billion, up 12.1% from FY2024.
- Assets has increased in each of the last three years, with a five-year compound annual growth rate of 25.6% (FY2020 to FY2025).
- Going back by year, Assets was $1.28 billion in FY2024 (+42.0%), $904.42 million in FY2023 (+19.0%), $760.09 million in FY2022 (-1.5%) and $771.6 million in FY2021 (+67.3%).
- The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2010.
- Year-over-year, Assets has increased for 14 consecutive quarters, with growth averaging 27.1% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2021 (growth of 67.3%), and the weakest in Q4 2022 (a decline of 1.5%).
- Business Quant data shows ANIP's Assets at $1.42 billion (Q1 2026), $1.44 billion (Q4 2025) and $1.41 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Ani Pharmaceuticals | 1.78 Bn | 565.34 Mn | 165.89 Mn | 1.49 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Bn |
| Mar 31, 2026 | 1.42 Bn |
| Dec 31, 2025 | 1.44 Bn |
| Sep 30, 2025 | 1.41 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Mar 31, 2025 | 1.29 Bn |
| Dec 31, 2024 | 1.28 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 920.75 Mn |
| Mar 31, 2024 | 914.52 Mn |
| Dec 31, 2023 | 904.42 Mn |
| Sep 30, 2023 | 889.91 Mn |
| Jun 30, 2023 | 859.34 Mn |
| Mar 31, 2023 | 765.22 Mn |
| Dec 31, 2022 | 760.09 Mn |
| Sep 30, 2022 | 739.11 Mn |
| Jun 30, 2022 | 751.33 Mn |
| Mar 31, 2022 | 744.85 Mn |
| Dec 31, 2021 | 771.60 Mn |
| Sep 30, 2021 | 470.45 Mn |
API Access
Ani Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();